Safety and Efficacy Study of Eculizumab in Patients With Refractory Generalized Myasthenia Gravis
Status:
Terminated
Trial end date:
2011-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether eculizumab is safe and effective in the
treatment of patients with generalized myasthenia gravis despite treatment with various
immunosuppressants, such as prednisone, methotrexate, Cellcept, cyclosporine, and
cyclophosphamide, that are currently available.